Fifth Third Bancorp’s Bionano Genomics BNGO Stock Holding History

Fifth Third Bancorp’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$2	–	2646
2025 Q3	$2	Hold	1	–	–	﹤0.01%	2661
2025 Q2	$3	Hold	1	–	–	﹤0.01%	2558
2025 Q1	$3	Hold	1	–	–	﹤0.01%	2518
2024 Q4	$20	Hold	1	–	–	﹤0.01%	2505
2024 Q3	$32	Hold	1	–	–	﹤0.01%	2534
2024 Q2	$48	Hold	1	–	–	﹤0.01%	2441
2024 Q1	$79	Hold	1	–	–	﹤0.01%	2354
2023 Q4	$134	Hold	1	–	–	﹤0.01%	2482
2023 Q3	$215	Hold	1	–	–	﹤0.01%	2548
2023 Q2	$436	Hold	1	–	–	﹤0.01%	2559
2023 Q1	$794	Hold	1	–	–	﹤0.01%	2665
2022 Q4	$1.04K	Hold	1	–	–	﹤0.01%	2528
2022 Q3	$1K	Hold	1	–	–	﹤0.01%	2515
2022 Q2	$1K	Hold	1	–	–	﹤0.01%	2501
2022 Q1	$2K	Hold	1	–	–	﹤0.01%	2507
2021 Q4	$2K	Hold	1	–	–	﹤0.01%	2533
2021 Q3	$4K	Hold	1	–	–	﹤0.01%	2244
2021 Q2	$5K	Hold	1	–	–	﹤0.01%	2187
2021 Q1	$6K	Buy	+1	New	+$5.64K	﹤0.01%	2135

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return

Fifth Third Bancorp's BNGO Position: Q4 2025 in Review

Fifth Third Bancorp sold out of Bionano Genomics (BNGO) in Q4 2025, closing a stake of 1 share — an estimated $2 sold.

Fifth Third Bancorp first reported a position in BNGO in Q1 2021 and held it in 19 quarters. The position peaked at $6K in Q1 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q4 2025.

Fifth Third Bancorp reported no remaining Bionano Genomics position as of Q4 2025 after selling out during the quarter.
Fifth Third Bancorp sold 1 Bionano Genomics share in Q4 2025, an estimated $2.
Fifth Third Bancorp first reported a position in Bionano Genomics in Q1 2021 and held it in 19 quarters.
Fifth Third Bancorp's Bionano Genomics position peaked at $6K in Q1 2021.
32 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2025.

Based on Fifth Third Bancorp's 13F filing for Q4 2025, filed 2 Feb 2026.